Sale!

ALPL Gene Hypophosphatasia Childhood Genetic Test

Original price was: $700.Current price is: $500.

-29%

The ALPL Gene Hypophosphatasia Childhood NGS Genetic DNA Test is a comprehensive genetic analysis designed to detect mutations in the ALPL gene responsible for childhood-onset hypophosphatasia. This rare metabolic bone disorder affects bone mineralization and can lead to serious skeletal complications if left undiagnosed. Using Next-Generation Sequencing (NGS) technology, this test provides precise identification of genetic variants that cause impaired alkaline phosphatase activity. Early detection through this $500 USD test enables timely intervention, appropriate treatment planning, and improved long-term outcomes for affected children. The test is particularly valuable for children showing symptoms of bone deformities, dental abnormalities, or unexplained fractures. Results are typically available within 3-4 weeks, providing families with crucial information for managing this complex condition.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

ALPL Gene Hypophosphatasia Childhood NGS Genetic DNA Test

Comprehensive Genetic Analysis for Childhood Metabolic Bone Disorders

The ALPL Gene Hypophosphatasia Childhood NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying genetic mutations associated with childhood-onset hypophosphatasia. This rare inherited metabolic disorder affects bone mineralization and can have significant implications for a child’s skeletal development and overall health. Through advanced Next-Generation Sequencing technology, our test provides unparalleled accuracy in detecting ALPL gene variants that disrupt alkaline phosphatase function, enabling early intervention and personalized treatment strategies.

What This Test Measures and Detects

This comprehensive genetic analysis specifically targets the ALPL (alkaline phosphatase, liver/bone/kidney) gene, which encodes tissue-nonspecific alkaline phosphatase (TNSALP). The test identifies:

  • Pathogenic variants and mutations in the ALPL gene
  • Single nucleotide polymorphisms (SNPs) affecting enzyme function
  • Deletions, insertions, and copy number variations
  • Compound heterozygous and homozygous mutations
  • Novel genetic variants with potential clinical significance

Who Should Consider This Test

This genetic test is recommended for children presenting with symptoms suggestive of hypophosphatasia, including:

  • Unexplained bone pain or tenderness
  • Recurrent fractures with minimal trauma
  • Delayed motor development and walking
  • Premature loss of deciduous teeth
  • Skeletal deformities or bowing of limbs
  • Short stature disproportionate to family height
  • Family history of metabolic bone disorders
  • Abnormal dental X-rays showing enlarged pulp chambers
  • Rickets-like bone changes without vitamin D deficiency

Clinical Benefits of Early Detection

Early genetic diagnosis through the ALPL Gene Hypophosphatasia Test provides numerous advantages:

  • Precise Diagnosis: Differentiates hypophosphatasia from other bone disorders
  • Personalized Treatment: Enables targeted enzyme replacement therapy
  • Family Planning: Provides genetic counseling for future pregnancies
  • Proactive Management: Allows early intervention to prevent complications
  • Improved Outcomes: Reduces risk of severe skeletal deformities
  • Comprehensive Care: Facilitates multidisciplinary approach involving endocrinologists, orthopedic specialists, and dentists

Understanding Your Test Results

Our comprehensive genetic report provides detailed interpretation of your results:

  • Positive Result: Indicates presence of pathogenic ALPL gene mutations confirming hypophosphatasia diagnosis
  • Negative Result: Suggests absence of detectable mutations, though clinical correlation is essential
  • Variant of Uncertain Significance: Identifies genetic changes requiring further clinical evaluation
  • Carrier Status: Detects individuals with single mutation who may pass the condition to offspring

All results are accompanied by detailed clinical interpretation and recommendations for next steps. Genetic counseling is strongly recommended to fully understand the implications of your results and discuss appropriate management strategies.

Test Pricing and Details

Test Feature Details
Test Name ALPL Gene Hypophosphatasia Childhood NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

Before scheduling your test, please ensure:

  • Complete clinical history of the patient
  • Genetic counseling session to document family pedigree
  • Review of symptoms and previous diagnostic tests
  • Discussion of potential implications and management options

Nationwide Accessibility

We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Miami, Seattle, Boston, and Phoenix. Our network of certified genetic counselors and medical professionals ensures you receive comprehensive support throughout the testing process.

Take the Next Step Toward Diagnosis

Don’t let uncertainty about your child’s bone health continue. Early genetic testing can provide the answers you need to make informed decisions about treatment and management. Our team of genetic specialists is ready to guide you through the testing process and help you understand the results.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your ALPL Gene Hypophosphatasia Childhood NGS Genetic DNA Test. Take advantage of our special discounted price of $500 USD and give your child the best chance for optimal bone health and development.